Meta-analysis of 13 RCTs (2002–2024; eight countries) found VR reduced pain (SMD −0.76) and anxiety (SMD −1.53), largely ...

In stage II–IIIA disease, adjuvant osimertinib reduced mortality risk by 47%, with 74% alive at eight years versus 58% with ...

Employers that decide to stop covering GLP-1s for weight loss are increasingly pairing that decision with support for the ...

Poh says treatment of follicular lymphoma is entering an exciting era in follicular lymphoma with multiple treatment options ...

Chad Hatfield, Pharm.D., M.H.A., BCPS, vice president and chief pharmacy officer of UC Davis Health, says pharmacists are embedded in “nearly all specialties," with more than 150 holding board ...

Divergent stakeholder needs emerged, with physicians prioritizing PA reduction and access tools, while patients prioritize affordability education, coverage clarity, and ongoing adherence support.

The treatment landscape continues to evolve, Poh says, and move away from a one-size-fits-all approach toward more ...